The spread of Hepatitis worldwide.
The liver is also known as a silent organ, because the majority of infections are asymptomatic until the hepatitis outbreak. Global Overview: 80% of primary liver cancer is caused by chronic hepatitis B. Each year, about 1.2 million people die from hepatitis B-related chronic liver diseases.
Asia: This region carries the highest incidence of Hepatitis B, carriers of Hepatitis B accounts to about 10 percent of the total population, or more than 100 million people. In South East Asia, each year about 25 million deaths are caused from liver diseases, and there are many more patients who suffer from long-term liver infection and diseases.
China: The country has the highest ranking with people infected with HBV, about 120 million people (about 1 out of 12 people is infected), and around 30 million people suffer from chronic type Hepatitis B.
Taiwan: Liver cancer is ranked number 2 in the top 10 cancer caused deaths. Every year, 7 to 8 thousand people die due to lung cancer, and Hepatitis B carriers is calculated at 3 million people (average of 1 out of every 7 people is a carrier).

Significant difference of micronutrients found in Hepatitis B carriers and healthy people.
Clinical studies show that the micronutrients status changes in carriers or patients of viral hepatitis, such as the rise in oxidative stress, the rise in percentage of heavy metals and microelements. These symptoms reduce the body’s immune, anti-oxidize and anti-virus abilities, which therefore, affect the cure rate.
Related studies show that, carotenoids, folate, vitamin B2, vitamin B12, vitamin C, iron, zinc, copper, selenium and other micronutrients have immune ability, and also affect the patient’s susceptibility for infectious diseases and cure rate.
Therefore, Hepatitis B patients can take supplement externally to replenish the micronutrients status, which may decrease side affects of Hepatitis B therapy, also improving the cure rate.

FEBICOについて
我々遠東生物科技(股)会社は、台湾でクロレラとスピルリナのメーカーとして、30年以上生産、培養、卸し事業を経営しております。欧米、日本、韓国、マレーシアなど、数多いの海外企業と長年も連携し、いつもご好評を頂いてまいりました。先端の設備と技術を備え、クロレラとスピルリナの原末は100﹪打錠できます。そのほかCGF、SGF、錠剤など様々な規格があり、顧客のニーズにこたえる自信があります。
弊社の工場は汚染ゼロの台湾南部にあります。純浄な水質にたっぷりな日光で培養したクロレラとスピルリナは高品質の誇りがあり、業界で競争できる値段を堅持しております。生産量も一年中提供できます。遠東生物科技(股)会社は、欧州連合で最も厳しいドイツ「Naturland」認証、HACCP認証、ISO 22000:2005認証、USDA/ NOPとGMP認証を取得しています。品質はご安心してください。

Christine Huang

FEBICO 遠東生物科技(股)会社
Tel: 886-2-26558198
Fax: 886-2-26558196
Email:
Website:
<a href=

このプレスリリースを 
PDFでダウンロードする or QRコード印刷する


👤 発行者について

FEBICO 遠東生物科技(股)会社

前へ | 次へ